|Videos|July 16, 2020

I/O-Based Therapy in Non–Small Cell Lung Cancer

Author(s)Neal E. Ready, MD, PhD, Duke University Medical Center, Stephen Liu, MD, MedStar Georgetown University Hospital

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Related to this article

April 3rd, 2026

ImmunoLogic, Episode 9: "Rewiring Immunotherapy for High-Risk Neuroblastoma" With Kristopher R. Bosse, MD

In episode 9 of ImmunoLogic, Kristopher Bosse, MD, and the cohosts discussed how immunotherapy is reshaping treatment for high-risk neuroblastoma.

I/O-Based Therapy in Non–Small Cell Lung Cancer

Related to this article

Trending on CGTlive®

Mivocabtagene Autoleucel Shows Durable 1-year Benefit in SPS, gMG